Skip to contentY
Yubo International Biotech Ltd
Y
YBGJYubo International Biotech Ltd Q3 2022 · 10-Q
Revenue$14.58K$14.58Kno prior Q3 2021 on file Net Income-$238.10K-$238.10Kno prior Q3 2021 on file EPS, diluted—
Operating Income-$238,270— The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Yubo International Biotech Ltd · CIK 895464 · Engraved from SEC EDGAR
Operating Cash Flowderived$55,236— Free Cash Flowderived$55,236— Margins · derivedGross margin65.8%
Operating margin-1634.2%
Net margin-1633.0%
ended Sep 30, 2022 · filed Nov 16, 2022 · 47 d after period end